These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22208596)

  • 21. A long-term follow-up of botulinum toxin A in cervical dystonia.
    Mohammadi B; Buhr N; Bigalke H; Krampfl K; Dengler R; Kollewe K
    Neurol Res; 2009 Jun; 31(5):463-6. PubMed ID: 19278576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
    Marciniec M; Szczepańska-Szerej A; Rejdak K
    Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
    Misra VP; Colosimo C; Charles D; Chung TM; Maisonobe P; Om S;
    J Neurol; 2018 Feb; 265(2):402-409. PubMed ID: 29270685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability, feasibility and satisfaction of telemedicine evaluations for cervical dystonia.
    Fraint A; Stebbins GT; Pal G; Comella CL
    J Telemed Telecare; 2020 Oct; 26(9):560-567. PubMed ID: 31208263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia.
    Dressler D; Paus S; Seitzinger A; Gebhardt B; Kupsch A
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1014-9. PubMed ID: 23687362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia.
    Scontrini A; Conte A; Fabbrini G; Colosimo C; Di Stasio F; Ferrazzano G; Berardelli A
    Mov Disord; 2011 Mar; 26(4):742-6. PubMed ID: 21506155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-reported treatment impressions and satisfaction of papulopustular rosacea patients treated with doxycycline, USP, 40 mg capsules.
    Johnson SM; LeVine P
    J Drugs Dermatol; 2011 Dec; 10(12):1376-81. PubMed ID: 22134561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm.
    Fezza J; Burns J; Woodward J; Truong D; Hedges T; Verma A
    J Neurol Sci; 2016 Aug; 367():56-62. PubMed ID: 27423565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.
    Müller J; Kemmler G; Wissel J; Schneider A; Voller B; Grossmann J; Diez J; Homann N; Wenning GK; Schnider P; Poewe W;
    J Neurol; 2002 Jul; 249(7):842-6. PubMed ID: 12140667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
    Oshima M; Deitiker PR; Jankovic J; Duane DD; Aoki KR; Atassi MZ
    J Neuroimmunol; 2011 Dec; 240-241():121-8. PubMed ID: 22079193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
    Jankovic J; Adler CH; Charles D; Comella C; Stacy M; Schwartz M; Manack Adams A; Brin MF
    J Neurol Sci; 2015 Feb; 349(1-2):84-93. PubMed ID: 25595221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensorimotor network in cervical dystonia and the effect of botulinum toxin treatment: a functional MRI study.
    Opavský R; Hluštík P; Otruba P; Kaňovský P
    J Neurol Sci; 2011 Jul; 306(1-2):71-5. PubMed ID: 21492880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
    Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O
    Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors of long-standing improvement in cervical dystonia, treated with botulinum A toxin].
    Sławek J; Cielecka A; Duzyński W
    Neurol Neurochir Pol; 2002; 36(1):47-56. PubMed ID: 12053615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of botulinum toxin for cervical dystonia. A comparison of methods for evaluation.
    Odergren T; Tollbäck A; Borg J
    Scand J Rehabil Med; 1994 Dec; 26(4):191-5. PubMed ID: 7878393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of dystonia in Japan].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    Rinsho Shinkeigaku; 2005 Sep; 45(9):634-42. PubMed ID: 16248394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.